150 related articles for article (PubMed ID: 15657642)
21. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
[TBL] [Abstract][Full Text] [Related]
22. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
23. Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound.
Baazaoui N; Iqbal K
Alzheimers Res Ther; 2017 Jun; 9(1):45. PubMed ID: 28655344
[TBL] [Abstract][Full Text] [Related]
24. Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances.
Thal DR; Capetillo-Zarate E; Larionov S; Staufenbiel M; Zurbruegg S; Beckmann N
Neurobiol Aging; 2009 Dec; 30(12):1936-48. PubMed ID: 18359131
[TBL] [Abstract][Full Text] [Related]
25. Cerebral vascular amyloid seeds drive amyloid β-protein fibril assembly with a distinct anti-parallel structure.
Xu F; Fu Z; Dass S; Kotarba AE; Davis J; Smith SO; Van Nostrand WE
Nat Commun; 2016 Nov; 7():13527. PubMed ID: 27869115
[TBL] [Abstract][Full Text] [Related]
26. Early pathologic amyloid induces hypersynchrony of BOLD resting-state networks in transgenic mice and provides an early therapeutic window before amyloid plaque deposition.
Shah D; Praet J; Latif Hernandez A; Höfling C; Anckaerts C; Bard F; Morawski M; Detrez JR; Prinsen E; Villa A; De Vos WH; Maggi A; D'Hooge R; Balschun D; Rossner S; Verhoye M; Van der Linden A
Alzheimers Dement; 2016 Sep; 12(9):964-976. PubMed ID: 27107518
[TBL] [Abstract][Full Text] [Related]
27. Geniposide attenuates insulin-deficiency-induced acceleration of β-amyloidosis in an APP/PS1 transgenic model of Alzheimer's disease.
Zhang Y; Yin F; Liu J; Liu Z; Guo L; Xia Z; Zidichouski J
Neurochem Int; 2015 Oct; 89():7-16. PubMed ID: 25882165
[TBL] [Abstract][Full Text] [Related]
28. Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure.
Rockenstein E; Ubhi K; Trejo M; Mante M; Patrick C; Adame A; Novak P; Jech M; Doppler E; Moessler H; Masliah E
BMC Neurosci; 2014 Jul; 15():90. PubMed ID: 25047000
[TBL] [Abstract][Full Text] [Related]
29. Prenatal high-fat diet alters the cerebrovasculature and clearance of β-amyloid in adult offspring.
Hawkes CA; Gentleman SM; Nicoll JA; Carare RO
J Pathol; 2015 Mar; 235(4):619-31. PubMed ID: 25345857
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.
Fragkouli A; Tsilibary EC; Tzinia AK
Neurobiol Dis; 2014 Oct; 70():179-89. PubMed ID: 25008761
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis.
Carro E; Trejo JL; Gerber A; Loetscher H; Torrado J; Metzger F; Torres-Aleman I
Neurobiol Aging; 2006 Sep; 27(9):1250-7. PubMed ID: 16183170
[TBL] [Abstract][Full Text] [Related]
32. Age-dependent cerebrovascular abnormalities and blood flow disturbances in APP23 mice modeling Alzheimer's disease.
Beckmann N; Schuler A; Mueggler T; Meyer EP; Wiederhold KH; Staufenbiel M; Krucker T
J Neurosci; 2003 Sep; 23(24):8453-9. PubMed ID: 13679413
[TBL] [Abstract][Full Text] [Related]
33. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
34. Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease.
Kimbrough IF; Robel S; Roberson ED; Sontheimer H
Brain; 2015 Dec; 138(Pt 12):3716-33. PubMed ID: 26598495
[TBL] [Abstract][Full Text] [Related]
35. Memantine improves spatial learning and memory impairments by regulating NGF signaling in APP/PS1 transgenic mice.
Liu MY; Wang S; Yao WF; Zhang ZJ; Zhong X; Sha L; He M; Zheng ZH; Wei MJ
Neuroscience; 2014 Jul; 273():141-51. PubMed ID: 24846616
[TBL] [Abstract][Full Text] [Related]
36. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
37. Transgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer's disease.
Ongali B; Nicolakakis N; Lecrux C; Aboulkassim T; Rosa-Neto P; Papadopoulos P; Tong XK; Hamel E
Am J Pathol; 2010 Dec; 177(6):3071-80. PubMed ID: 21088218
[TBL] [Abstract][Full Text] [Related]
38. Molecular and functional dissection of TGF-beta1-induced cerebrovascular abnormalities in transgenic mice.
Buckwalter M; Pepper JP; Gaertner RF; Von Euw D; Lacombe P; Wyss-Coray T
Ann N Y Acad Sci; 2002 Nov; 977():87-95. PubMed ID: 12480736
[TBL] [Abstract][Full Text] [Related]
39. Anticoagulants for Treatment of Alzheimer's Disease.
Grossmann K
J Alzheimers Dis; 2020; 77(4):1373-1382. PubMed ID: 32925057
[TBL] [Abstract][Full Text] [Related]
40. Alzheimer's disease-like cerebrovascular pathology in transforming growth factor-beta 1 transgenic mice and functional metabolic correlates.
Wyss-Coray T; Lin C; von Euw D; Masliah E; Mucke L; Lacombe P
Ann N Y Acad Sci; 2000 Apr; 903():317-23. PubMed ID: 10818521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
